Skip to content

To explore safety and performance of Thoracic Trocar Catheter in Adult & Paediatric subjects in Indian Population.

A prospective, single arm, multi-centric, post market clinical follow-up of Thoracic Trocar Catheter to explore its safety and performance in Adult & Paediatric subjects in Indian Population. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/059216
Enrollment
100
Registered
2023-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: (1)Thoracic Trocar Catheter – GS-5030. (2)Chest Drainage Catheter – Straight(GS-5010) / Right Angle (GS-5011A). (3)Flexo Cath-Straight (GS-5034) / Right Angle (GS-5034A). : Device is si

Sponsors

Romsons Group Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and Females (Adult & Pediatric) who are expected to require Thoracic Trocar Catheter. 2. Subject who can provide Informed Consent Form (Adult) in writing and medically in a position to undergo consent and screening process OR in case of Pediatrics, parent of child/LAR (Legally Acceptable Representative) can provide Informed Assent Form (Child). 3. The subject who is willing and able to comply with the requirement of the follow-up. OR in case of Pediatrics, parent of child/LAR (Legally Acceptable Representative) who is willing and able to comply with the requirement of the follow-up.

Exclusion criteria

Exclusion criteria: 1. Subject who present with medical emergency, where treatment is more priority than the informed consent/informed assent process. 2. Subject with bleeding disorder, extensive malignant skin involvement, multicoated effusions, located fluid accumulations, hepatic hydrothorax. 3. Subject, who cannot provide Informed Consent Form (Adult) such as unconscious, mentally challenged subject, OR in case of Pediatrics, parent of child/LAR (Legally Acceptable Representative) who cannot provide Informed Assent Form (Child) or give permission etc. 4. Any known allergy with any of the material of Thoracic Trocar Catheter and its component(s). 5. Subject who is pregnant or breast feeding. 6. Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital. 7. Participation in another research study involving an active investigation within 30 days prior to consent.

Design outcomes

Primary

MeasureTime frame
1. Quick non-operative pleural, chest drainage for the relief of chest conditions such as tensions pneumothorax. 2. Drainage of air / blood / pus / chyle / other fluids from pleural space. 3. Accomplishment of intended application. 4. Material compatibility with the tissue and body fluids.Timepoint: Device maximum use duration is 5 days.

Secondary

MeasureTime frame
1. Fitment with standard devices or under water seal drainage system. 2. Relief of clinical symptoms. Timepoint: Device maximum use duration is 5 days.

Countries

India

Contacts

Public ContactDr Anoop Batra

Romsons Group Private Limited

cta2@romsons.com8006599926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026